Marpai Q2 revenue falls due to turnover and continued customer pruning

Marpai

13/08/2026 22:58

Overview
US healthcare technology firm's Q2 revenue fell 10.5% yr/yr due to customer turnover and pruning
Gross margin improved to 23.9% from 16.0% as cost of revenue decreased faster than revenue
Company completed debt restructuring and raised $12.1 mln in private placement after quarter-end

Outlook
Company expects capital raise to support operations and strategic priorities
Marpai plans continued use of AI and technology to improve efficiency and margins
Company remains focused on profitable customer base growth and building a scalable platform

Result Drivers
CUSTOMER PRUNING - Revenue declined due to turnover and continued pruning of customer base
CLAIMS PROCESSING COSTS - Cost of revenue decreased faster than revenue due to a reduction in claims processing expense
COST REDUCTIONS - Lower information technology, sales and marketing, and facilities expenses contributed to lower total costs

Company press release: ID:nPnbBnD49a

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
 
$4.17 mln
 
Q2 Loss Per Share
 
$0.18
 

Reuters Recommended Reads
Aug 11 - DarioHealth Q2 revenue falls on pharma exit; gross margin improves
Aug 13 - Healthcare Triangle Q2 revenue jumps 158% on acquisitions
Aug 12 - OptimizeRx Q2 revenue beats estimates on operating resilience; reaffirms outlook

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)